Your browser doesn't support javascript.
loading
CTLA4 mRNA is downregulated by miR-155 in regulatory T cells, and reduced blood CTLA4 levels are associated with poor prognosis in metastatic melanoma patients.
Vaddi, Prasanna Kumar; Osborne, Douglas Grant; Nicklawsky, Andrew; Williams, Nazanin K; Menon, Dinoop Ravindran; Smith, Derek; Mayer, Jonathan; Reid, Anna; Domenico, Joanne; Nguyen, Giang Huong; Robinson, William A; Ziman, Melanie; Gao, Dexiang; Zhai, Zili; Fujita, Mayumi.
Afiliación
  • Vaddi PK; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Osborne DG; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Nicklawsky A; University of Colorado Cancer Center Biostatistics Core, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Williams NK; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Menon DR; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Smith D; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Mayer J; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Reid A; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Domenico J; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Nguyen GH; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Robinson WA; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Ziman M; School of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia.
  • Gao D; School of Biomedical Science, University of Western Australia, Perth, WA, Australia.
  • Zhai Z; University of Colorado Cancer Center Biostatistics Core, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
  • Fujita M; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Front Immunol ; 14: 1173035, 2023.
Article en En | MEDLINE | ID: mdl-37197667
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / MicroARNs / Melanoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / MicroARNs / Melanoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos